Skip to search formSkip to main contentSkip to account menu

Shigella Vaccines

Known as: Shigella Vaccines [Chemical/Ingredient], Shigella vaccine, Vaccines, Shigella 
Vaccines or candidate vaccines used to prevent bacillary dysentery (DYSENTERY, BACILLARY) caused by species of SHIGELLA.
National Institutes of Health

Related topics

Related topics

10 relations

Broader (1)

Bacterial Vaccines
In BloodProcess of secretionShigella dysenteriaeagonists

Narrower (1)

WRSF2G11

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Oral Shigella Vaccines
2016
2016
Shigella Vaccine Development: Finding the Path of Least Resistance
ABSTRACT Shigella spp. represent the second most common etiologic pathogen causing childhood diarrhea in developing countries… 
2016
2016
Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production
ABSTRACT There is a significant need for an effective multivalent Shigella vaccine that targets the most prevalent serotypes… 
2006
2006
Developing live Shigella vaccines using lambda Red recombineering.
Live attenuated Shigella vaccines have shown promise in inducing protective immune responses in human clinical trials and as… 
2001
2001
Effect of Intranasal Immunization with Bivalent Shigella Vaccine on Mouse NALT,GALT and Spleenic Lymphocytes
To observe the effect of intranasal immunization of Shigella vaccine on the antigen specific antibody secreting cells and the… 
1999
1999
Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile.
BACKGROUND Shigella is an important cause of diarrheal disease in children in developing countries. The increasing prevalence of… 
1999
1999
Native and Mutant Forms of Cholera Toxin and Heat-Labile Enterotoxin Effectively Enhance Protective Efficacy of Live Attenuated and Heat-Killed Shigella Vaccines
ABSTRACT Both native and mutant forms of cholera toxin (CT) and heat-labile enterotoxin (LT) are effective adjuvants for antigens… 
Review
1994
Review
1994
An update on Shigella vaccines.
Recent advances in the understanding of the molecular virulence mechanisms of Shigella have helped to develop a new generation of… 
1987
1987
A prospective epidemiologic study of shigellosis in the Israel Defense Forces: implications for the use of shigella vaccines.
Recent development of new shigella vaccines has renewed interest in the current epidemiology of shigellosis in endemic regions. A… 
1967
1967
Biological Properties of Freeze-Dried Attenuated Shigella Vaccines
Summary Two Shigella flexneri 2 a strains of reduced virulence were lyophilized and their biological properties determined. When… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)